NCT03012022View on ClinicalTrials.gov

Cleveland Heart and Metabolic Prevention Study

Active, not recruitingOBSERVATIONAL
Enrollment

1,208

Participants

Timeline

Start Date

November 8, 2010

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Heart Failure Risk Factors in Healthy Individuals
Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

The Cleveland Clinic

OTHER

NCT03012022 - Cleveland Heart and Metabolic Prevention Study | Biotech Hunter | Biotech Hunter